News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39 Results
Type
Article (1)
Press Release (38)
Section
Business (20)
Deals (3)
Drug Development (1)
News (23)
Tag
Alliances (14)
Clinical research (1)
Mergers & acquisitions (3)
NextGen Class of 2024 (1)
People (4)
Phase I (1)
Startups (1)
Date
Last 365 days (1)
2024 (1)
2023 (1)
2022 (1)
2021 (2)
2020 (1)
2019 (1)
2017 (2)
2016 (1)
2015 (2)
2014 (2)
2013 (2)
2012 (3)
2011 (2)
2010 (4)
Location
Asia (4)
Europe (4)
39 Results for "stemgent".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
REPROCELL USA Receives Funding from Maryland Stem Cell Research Fund (MSCRF)
REPROCELL USA is proud to announce that it has received funding from MSCRF for both proposals it has submitted for the MSCRF’s January 2024 grant cycle.
June 5, 2024
·
2 min read
Deals
ReproCELL Acquires The iPS Cell Business Unit Of Stemgent, Inc.
September 9, 2014
·
1 min read
Deals
Stemgent, Inc. Sells The Stem Cell Reagent And Services Business Unit
October 2, 2014
·
1 min read
Stemgent, A ReproCELL Group Company Launches A New High Performance Self-replicative RNA Reprogramming Kit
June 30, 2015
·
1 min read
Business
Stemgent, A Reprogen, Inc. Company And Transposagen Biopharmaceuticals, Inc. Enter Into A Service Partnership Agreement Providing Genetically Engineered Stem Cells
February 19, 2015
·
2 min read
Business
Cellectis BioResearch and Stemgent Partner to Provide Custom Genome-Engineered iPS Cells
March 7, 2013
·
1 min read
Deals
Stemgent Completes Acquisition of Asterand plc’s Human Tissue Business
August 1, 2012
·
1 min read
Business
Stemgent and Pfizer Inc. Announce Collaboration
April 16, 2010
·
1 min read
Lone Star Bio
StemBioSys Announces Launch of CELLvo™ Atrial Cardiomyocyte, a Technological Leap Forward in Cardiotoxicity Screening
StemBioSys, Inc. announced the launch of CELLvo™ Atrial Cardiomyocyte, a “chamber specific” human induced pluripotent stem cell derived cardiomyocyte designed to function identically to human atrial cardiomyocytes.
June 13, 2023
·
4 min read
Genetown
Stemgent Finds $5.6 Million More
May 17, 2010
·
1 min read
1 of 4
Next